PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancer. - Cunningham ML; Vasquez-Gonzalez J; Barnada SM; Tchotorlishvili S; Jones L; Maguire R; Lewis G; Rizwan K; Deng J; Koachar S; Patel D; Shankle H; et al. (Molecular oncology, 2026)